Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons

NCT02556723 is registered in ClinicalTrials.gov with Retina Clinic, Sao Paulo, Brazil as lead sponsor.

NCT NCT02556723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02556723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Injections of Ziv-aflibercept for Macular Diseases: Diabetic Macular Edema, Wet AMD and Macular Edema Secondary to Vein Occlusons
Lead sponsor
Retina Clinic, Sao Paulo, Brazil
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2016
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration, branch retinal vein occlusion with macular edema, central retinal vein occlusion with macular edema, diabetic macular edema